Skip to content
TrialScanner

NCT05543928

Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism

Phase 3TerminatedOPKLead

Registry record

Lead sponsor
OPKO Health, Inc.
Conditions
Chronic Kidney Disease stage3; Chronic Kidney Disease stage4; Vitamin d Deficiency; Secondary Hyperparathyroidism
Primary completion
Jun 19, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05543928 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.